---
run_id: halo-evidence-vs-diagnosis-validation-v12-substrate-workflow-07
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v12
benchmark_version: halo-evidence-vs-diagnosis-validation-v12-v1
model_condition: substrate_workflow
run_number: 7
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 2048
seed: 703
prompt_source: condition packet (substrate_workflow) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
source_packet: a substrate preamble plus the full public-safe text of three reviewed source cards, then the frozen Advisor prompt - see run-packet.md
source_packet_sha256: b6cd135fd92e629c778a8282ec7993f44f89675e5f6dceea2232399cd10f2424
condition_packet_sha256: b6cd135fd92e629c778a8282ec7993f44f89675e5f6dceea2232399cd10f2424
output_file: model-outputs/substrate_workflow-07.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - substrate_workflow (run 07)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v12-v1`, condition `substrate_workflow`, run 7 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 703, on the frozen condition packet.

## Output

I recommend that you commit to the **Demand Cleanroom**.

### Recommendation: The Demand Cleanroom
You should recommend the Demand Cleanroom because your current "strong quarter" is contaminated by two distinct distortions described in the provided evidence:

1.  **The Halo Effect (BK-0048):** Your executive team is attributing specific traits—being "focused," "commercially disciplined," and "aligned"—to the product team because overall performance (expansion bookings) is up. According to BK-0048, these trait ratings are likely not independent evidence of a better process, but reflections of the performance signal. If bookings drop, these same traits will likely be re-described as "unfocused" or "misaligned."
2.  **Illusory Progress (BK-0007):** Your current metrics are "vanity numbers" or execution targets rather than validated learning. Expansion bookings rose, but the evidence suggests this was driven by a "temporary bundle price" (financial incentive) and a roadmap pitch (future promise), not the actual value of PlanPilot. BK-0007 argues that progress is only "validated" when it is based on empirical evidence of customer behavior.

The Demand Cleanroom is the only proposal that isolates the actual value of the product from these distortions. By removing the bundle price and the roadmap pitch, you test whether buyers actually value PlanPilot enough to pay for it today, providing the "validated learning" necessary to avoid scaling a product no one actually wants.

### The Strongest Reason Against It
The Demand Cleanroom carries a high immediate commercial risk: by stopping bundle-price offers and withholding the roadmap pitch, you may intentionally slow down expansion bookings or prolong sales cycles in the short term. In a high-pressure environment where the board is locking budgets in twelve days, the CEO may view this as "sabotaging" a winning streak to satisfy a theoretical research requirement.

### Evidence That Would Change My Mind
I would change this recommendation if the **Case Evidence Review** provided immediate, empirical proof that front-line benefits analysts were fundamentally changing their workflow because of PlanPilot (e.g., a high rate of "accepted" suggestions that replaced manual work).

Currently, your usage data is ambiguous (managers are just rerunning samples; analysts abandon the tool in the public sector). If the Case Evidence Review could prove that PlanPilot solves a decisive "challenge" (the **Diagnosis** step of the strategy kernel in BK-0001), then scaling would be a logical "coherent action." Without that proof, you are simply scaling an incentive structure, not a product.
